Chinese Journal of Antituberculosis ›› 2023, Vol. 45 ›› Issue (1): 67-72.doi: 10.19982/j.issn.1000-6621.20220280
• Original Article • Previous Articles Next Articles
Sheng Yunfeng, Qiu Meihua, Chen Yuanyuan, Sun Lifang, Zhen Libo()
Received:
2022-07-27
Online:
2023-01-10
Published:
2022-12-30
Contact:
Zhen Libo
E-mail:zlb8191@126.com
Supported by:
CLC Number:
Sheng Yunfeng, Qiu Meihua, Chen Yuanyuan, Sun Lifang, Zhen Libo. Research on mechanisms of dendritic cell miR-17 regulating naive CD4+T lymphocytes unevenly differentiating to Treg/Th17[J]. Chinese Journal of Antituberculosis, 2023, 45(1): 67-72. doi: 10.19982/j.issn.1000-6621.20220280
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20220280
[1] |
Khan N, Vidyarthi A, Pahari S, et al. Distinct Strategies Employed by Dendritic Cells and Macrophages in Restricting Mycobacterium tuberculosis Infection: Different Philosophies but Same Desire. Int Rev Immunol, 2016, 35(5):386-398. doi:10.3109/08830185.2015.1015718.
doi: 10.3109/08830185.2015.1015718. URL |
[2] |
Ali SZ, Langden SSS, Munkhzul C, et al. Regulatory Mechanism of MicroRNA Expression in Cancer. Int J Mol Sc, 2020, 21(5):1723. doi:10.3390/ijms21051723.
doi: 10.3390/ijms21051723. |
[3] |
Jámbor I, Szabó K, Zeher M, et al. The importance of microRNAs in the development of systemic autoimmune disorders. Orv Hetil, 2019, 160(15):563-572. doi:10.1556/650.2019.31349.
doi: 10.1556/650.2019.31349. URL |
[4] |
Kumar R, Sahu SK, Kumar M, et al. MicroRNA 17-5 p regulates autophagy in Mycobacterium tuberculosis-infected macrophages by targeting Mcl-1 and STAT3. Cell Microbiol, 2016, 18(5):679-691. doi:10.1111/cmi.12540.
doi: 10.1111/cmi.12540. URL |
[5] | 中华人民共和国国家卫生和计划生育委员会. WS 288—2017肺结核诊断. 2017-11-09. |
[6] |
Probst AV, Dunleavy E, Almouzni G. Epigenetic inheritance during the cell cycle. Nat Rev Mol Cell Biol, 2009, 10(3):192-206. doi:10.1038/nrm2640.
doi: 10.1038/nrm2640. URL |
[7] |
Shipony Z, Mukamel Z, Cohen NM, et al. Dynamic and static maintenance of epigenetic memory in pluripotent and somatic cells. Nature, 2014, 513(7516):115-119. doi:10.1038/nature13458.
doi: 10.1038/nature13458. URL |
[8] |
Gyorffy B, Bottai G, Fleischer T, et al. Aberrant DNA methy-lation impacts gene expression and prognosis in breast cancer subtypes. Int J Cancer, 2016, 138(1):87-97. doi:10.1002/ijc.29684.
doi: 10.1002/ijc.29684. URL |
[9] |
Boyne DJ, O’Sullivan DE, Olij BF, et al. Physical Activity, Global DNA Methylation, and Breast Cancer Risk: A Systema-tic Literature Review and Meta-analysis Cancer Epidemiol Biomarkers Prev, 2018, 27(11):1320-1331. doi:10.1158/1055-9965.EPI-18-0175.
doi: 10.1158/1055-9965.EPI-18-0175. URL |
[10] |
Scott-Browne JP, Shafiani S, Tucker-Heard G, et al. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med, 2007, 204(9): 2159-2169. doi:10.1084/jem.20062105.
doi: 10.1084/jem.20062105 pmid: 17709423 |
[11] |
Wergeland I, Assmus J, Dyrhol-Riise AM. T regulatory cells and immune activation in Mycobacterium tuberculosis infection and the effect of preventive therapy. Scand J Immunol, 2011, 73(3):234-242. doi:10.1111/j.1365-3083.2010.02496.x.
doi: 10.1111/j.1365-3083.2010.02496.x pmid: 21204895 |
[12] |
Jurado JO, Pasquinelli V, Alvarez IB, et al. IL-17 and IFN-γ. Leukoc Biol, 2012, 91(6):991-1002. doi:10.1189/jlb.1211619.
doi: 10.1189/jlb.1211619. URL |
[13] |
Mitchell PS, Parkin RK, Kroh EM, et al. Circulating micro-RNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A, 2008, 105(30):10513-10518. doi:10.1073/pnas.0804549105.
doi: 10.1073/pnas.0804549105 pmid: 18663219 |
[14] |
Fathizadeh H, Hayat SMG, Dao S, et al. Long Non-Coding RNA Molecules in Tuberculosis. Int J Biol Macromol, 2020, 156:340-346. doi:10.1016/j.ijbiomac.2020.04.030.
doi: S0141-8130(20)32884-1 pmid: 32283111 |
[15] |
Bettencourt P, Pires D, Anes E. Immunomodulating micro-RNAs of mycobacterial infections.Tuberculosis (Edinb), 2016, 97:1-7. doi:10.1016/j.tube.2015.12.004.
doi: 10.1016/j.tube.2015.12.004. URL |
[16] |
Tu H, Yang S, Jiang T, et al. Elevated pulmonary tuberculosis biomarker miR-423-5p plays critical role in the occurrence of active TB by inhibiting autophagosome-lysosome fusion. Emerg Microbes Infect, 2019, 8(1):448-460. doi:10.1080/22221751.2019.1590129.
doi: 10.1080/22221751.2019.1590129. URL |
[17] |
Najm A, Mason FM, Preuss P, et al. MicroRNA-17-5p Reduces Inflammation and Bone Erosions in Mice With Collagen-Induced Arthritis and Directly Targets the JAK/STAT Pathway in Rheumatoid Arthritis Fibroblast-like Synoviocytes. Arthritis Rheumatol, 2020, 72(12):2030-2039. doi:10.1002/art.41441.
doi: 10.1002/art.41441. URL |
[18] |
Ji Z, Xue W, Zhang L. Schisandrin B Attenuates Inflammation in LPS-Induced Sepsis Through miR-17-5p Downregula-ting TLR4. Inflammation, 2019, 42(2):731-739. doi:10.1007/s10753-018-0931-3.
doi: 10.1007/s10753-018-0931-3. URL |
[19] |
Oglesby IK, Venckon SF, Agrawal R, et al. miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production. Eur Respir, 2015, 46(5):1350-1360. doi:10.1183/09031936.00163414.
doi: 10.1183/09031936.00163414. URL |
[20] |
Tan L, Liu L, Jiang Z, et al. Inhibition of microRNA-17-5p reduces the inflammation and lipid accumulation, and up-regulates ATP-binding cassette transporterA 1 in atherosclerosis. J Pharmacol Sci, 2019, 139(4):280-288. doi:10.1016/j.jphs.2018.11.012.
doi: 10.1016/j.jphs.2018.11.012. URL |
[21] |
Kühtreiber WM, Tran L, Kim T, et al. Long term reduction in hyperglycemia in advanced type 1 diabetes: The value of induced aerobic glycolysis with BCG vaccinations. NPJ Vaccines, 2018, 3:23. doi:10.1038/s41541-018-0062-8.
doi: 10.1038/s41541-018-0062-8 pmid: 29951281 |
[22] |
Yang H, Barbi J, Wu C. et al. MicroRNA-17 Modulates Regu-latory T Cell Function by Targeting Co-regulators of the Foxp 3 Transcription Factor. Immunity, 2016, 45(1): 83-93. doi:10.1016/j.immuni.2016.06.022.
doi: 10.1016/j.immuni.2016.06.022. URL |
[1] | Wang Zeming, Shen Adong. Interpretation of the standard of Detection and preventive treatment of latent tuberculosis infection in children [J]. Chinese Journal of Antituberculosis, 2023, 45(1): 13-17. |
[2] | Yu Meiling, Zhang Chenchen, Wei Wenjing, Zhao Yuchuan, Zhuo Wenji, Zheng Lei. Study on high-concentration p-aminosalicylic acid resistant Mycobacterium tuberculosis induced in vitro and the mutation sites [J]. Chinese Journal of Antituberculosis, 2023, 45(1): 60-66. |
[3] | Wei Shuzhen, Zhao Yong, Lin Jian, Lin Shufang, Dai Zhisong. Analysis of genotype characteristics and drug resistance of Mycobacterium tuberculosis isolates in Fujian Province from 2017 to 2019 [J]. Chinese Journal of Antituberculosis, 2023, 45(1): 73-78. |
[4] | National Clinical Research Centre for Infectious Disease/The Third People’s Hospital of Shenzhen, Peking University Shenzhen Hospital, Peking Union Medical College Hospital of Chinese Academy of Medical Sciences, Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis, Shenzhen Key Laboratory of Inflammatory and Immune Diseases. Expert consensus on diagnosis and treatment of latent tuberculosis infection in patients with rheumatic diseases [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 869-879. |
[5] | Wang Yuxiang, Chen Qiuqi, Yu Xinxin, Zhan Senlin, Zhang Peize, Deng Guofang. 3HP regimen in the treatment of rheumatic diseases complicated with Mycobacterium tuberculosis latent infection:a prospective study [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 906-910. |
[6] | Xie Jingyi, Zou Ruifeng, Chen Yulan, Chen Yong, Liu Dongzhou, Hong Xiaoping. Analysis of clinical features and peripheral lymphocyte subsets of systemic lupus erythematosus patients complicated with tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 911-916. |
[7] | Cheng Xiao, Chen Zhe, Jiao Xuefeng, Yang Nan, Diao Sha, Ni Xiaofeng, Liu Zheng, He Siyi, Zeng Linan, Wan Chaomin, Kang Deying, Wu Bin, Ying Binwu, Zhang Hui, Zhao Rongsheng, Zhang Lingli. Efficacy and safety of recombinant Mycobacterium tuberculosis fusion proteins (EC) for the diagnosis of Mycobacterium tuberculosis infection: A system review [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 917-926. |
[8] | Wu Wenqi, Zhong Jianqiu, He Juan, Deng Guofang, Wang Qingwen. The research progress of the reactivation of latent tuberculosis infection in patients with rheumatic diseases [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 954-959. |
[9] | Dong Xiaowei, Guo Huixin, Zhang Chenchen, Wang Jiawen, He Junlei, Li Guanhai, Li Jianwei, Wen Wenpei. Application value of two-step detection of Mycobacterium tuberculosis infection screening in schools [J]. Chinese Journal of Antituberculosis, 2022, 44(8): 802-807. |
[10] | Li Yinhong, Liu Fanglin, Lu Zhenhui, Jiang Xin. Study on the mechanism of Oridonin against pathological damage of tuberculosis [J]. Chinese Journal of Antituberculosis, 2022, 44(8): 849-854. |
[11] | XIA Hui, ZHENG Yang, SONG Yuan-yuan. Interpretation of the Optimized broth microdilution plate methodology for drug susceptibility testing of Mycobacterium tuberculosis complex issued by World Health Organization [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 641-645. |
[12] | LIU Hai-ting, LI Dong-shuo, ZHANG Lei, WANG Ning, WANG Bin, DING Yang-ming, YAO Rong, LU Yu. A preliminary study on the synergy and mechanism of pyrifazimine and bedaquiline [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 646-653. |
[13] | DAI Xiao-wei, WANG Nen-han, CHEN Shuang-shuang, YANG Xin-yu, TIAN Li-li, CHEN Hong, ZHANG Hong-tai, LI Chuan-you. Assessing next-generation sequencing for Mycobacterium tuberculosis diagnosis in clinical sputum samples [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 669-679. |
[14] | JIA Hong-yan, DONG Jing, ZHANG Zong-de, PAN Li-ping. Progress and clinical application of immunological detection technology for Mycobacterium tuberculosis infection [J]. Chinese Journal of Antituberculosis, 2022, 44(7): 720-726. |
[15] | HE Yi-jun, CAO Xue-fang, GAO Lei. Interpretation of the Procedure of tuberculin skin test-interferon-gamma release assay two-step testing [J]. Chinese Journal of Antituberculosis, 2022, 44(5): 438-441. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||